NBW Capital’s Pfizer PFE Stock Holding History

NBW Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-67,933	Closed	-$2.25M	–	115
2023 Q3	$2.25M	Sell	67,933 -792	-1%	-$28K	0.55%	64
2023 Q2	$2.52M	Buy	68,725 +175	+0.3%	+$6.81K	0.59%	69
2023 Q1	$2.8M	Sell	68,550 -1,711	-2%	-$73.9K	0.68%	66
2022 Q4	$3.6M	Sell	70,261 -1,019	-1%	-$48.9K	0.92%	50
2022 Q3	$3.12M	Buy	71,280 +586	+0.8%	+$28.5K	0.84%	55
2022 Q2	$3.71M	Buy	+70,694	New	+$3.6M	1.02%	47
2022 Q1	–	Sell	-4,148	Closed	-$245K	–	93
2021 Q4	$245K	Sell	4,148 -2,098	-34%	-$104K	0.05%	78
2021 Q3	$269K	Sell	6,246 -1,737	-22%	-$77K	0.06%	81
2021 Q2	$313K	Sell	7,983 -1,827	-19%	-$71K	0.08%	79
2021 Q1	$355K	Buy	9,810 +1,100	+13%	+$39.1K	0.1%	76
2020 Q4	$321K	Buy	+8,710	New	+$319K	0.1%	75

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

NBW Capital's PFE Position: Q4 2023 in Review

NBW Capital sold out of Pfizer (PFE) in Q4 2023, closing a stake of 67,933 shares — an estimated $2.25M sold.

NBW Capital first reported a position in PFE in Q4 2020 and held it in 11 quarters. The position peaked at $3.71M in Q2 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

NBW Capital reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
NBW Capital sold 67,933 Pfizer shares in Q4 2023, an estimated $2.25M.
NBW Capital first reported a position in Pfizer in Q4 2020 and held it in 11 quarters.
NBW Capital's Pfizer position peaked at $3.71M in Q2 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on NBW Capital's 13F filing for Q4 2023, filed 31 Jan 2024.